ArticleInternational journal of clinical oncology2019

Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: a retrospective study.

Taro Iguchi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.